Flow cytometry analysis of tumors revealed that percentages of tumor-infiltrating CD8+ and CD4+ T cells were higher in right flank tumors of mice treated with the combined treatment (mCelyvir-ICOVIR5) (Figure 7A and Supplementary Figure 7A). This evidence concerns the gene CD8A and neoplasm.